In patients with ST-elevation myocardial infarction, baseline serum Tβ4 was lower than in healthy controls.
In plain wordsIn people with a heart attack, the body's own Tβ4 level was lower than in healthy people at admission.
- Peptide
- Thymosin beta-4 (human)
- Outcome
- DecreaseSerum Tβ4 at admission, STEMI patients versus controls
- Study
n = 48
- Comparator
- Healthy controls
- Outcome group
- Endogenous peptide levels · Cardiovascular
Measurements
- Serum Tβ4
- 2.9 µg/ml
- controls
- Serum Tβ4
- 1.5 µg/ml
- STEMI at baseline
Source sentences
Compared to controls, baseline levels of high-density lipoprotein cholesterol (46.2±8.9 vs. 34.2±7.2 mg/dl, p<0.001) and Tβ4 (2.9±1.5 vs. 1.5±1.0 µg/ml, p<0.001) were significantly lower, and white blood cell counts (7.6±2.2 vs. 11.4±3.0 10³/µl, p<0.001) were significantly higher in the STEMI group.
2 context sentences(design, population, supporting numbers)
The study included 24 consecutive patients (7 females, 17 males; mean age 55.0±10.9 years) who underwent successful primary PCI for STEMI and 24 age- and sex-matched healthy controls (13 females, 11 males; mean age 57.5±11.7 years) with angiographically normal coronary arteries.
To determine Tβ4 levels, blood samples were obtained from STEMI patients on admission and 48 hours after successful PCI, and from controls immediately after coronary angiography.
This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.